212Pb-TCMC-OI-3

N/A

Report date: 2025/11/18 13:23:00

Base Information

Drug Name212Pb-TCMC-OI-3
Drug Alias Name212Pb-TCMC-OI-3212Pb-TCMC-chOI-3212Pb-TCMC-mOI-3
ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionAnti-Melanoma cell adhesion molecule
TargetsMelanoma cell adhesion molecule
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoinvent AsUniversity Of Oslo
China Registration ClassN/A

Develop Information

Active CompaniesOncoinvent AsUniversity Of Oslo
Inactive CompaniesN/A
Active IndicationsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A